The A-share innovative drug concept continued its strong performance, with 3SBio and Weikang Pharmaceutical rising by more than 10%, and Asia Pacific Pharmaceutical, Lianhuan Pharmaceutical, Shutaishan, and Zhongyuan Union Pharmaceutical following su

2025-11-03

The A-share innovative drug concept continued its strong performance, with 3SBio and Weikang Pharmaceutical rising by more than 10%, and Asia Pacific Pharmaceutical, Lianhuan Pharmaceutical, Shutaishan, and Zhongyuan Union Pharmaceutical following suit.